Food and Drug Administration (FDA) encourage patients to report any adverse effects.
It is important to monitor and collect data on patient experiences to ensure the safety and effectiveness of Biaxin and other medications. The feedback from patients can help identify potential issues and improve drug development and prescription practices.
References:
- National Library of Medicine. “Clarithromycin.” MedlinePlus, U.S. National Library of Medicine, 20 Jan. 2022, https://medlineplus.gov/druginfo/meds/a692005.html.
- Food and Drug Administration. “CDER Conversation: Generic Drugs: Safe. Effective. Affordable.” U.S. Food and Drug Administration, 2019, https://www.fda.gov/drugs/drug-information-consumers/cder-conversation-generic-drugs-safe-effective-affordable.